Ministry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015
|
|
- Willa Houston
- 5 years ago
- Views:
Transcription
1 Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: v2016 Page 1
2 GLOSSARY Cumulative Prevalence It is also known as Prevalence for Life. Cases meet case definition criteria to qualify in a given year, and are then carried forward to show as a case every year thereafter. This measure is helpful for determining prevalence related to life long chronic disease, but less useful for conditions that may be episodic (e.g., mood disorders, substance use problem, etc.). Episodic Prevalence Cases meet case definition criteria to qualify in a given year, and are then carried forward in all subsequent years with at least one condition related code including ICD diagnostic codes, procedure codes or drugs in any specific year. Annual Prevalence Cases meet case definition criteria to qualify in each given year. Can be used as a quality measure to understand how it compares to cumulative prevalence or how it behaves over time. Annual Service Utilization Prevalence Cases meet case definition criteria in a given year by virtue of one hospital diagnosis (MRDX) or one physician claim with diagnosis (first position only). Cases are not carried forward from year to year. This utilization prevalence measure is useful for describing the number of people or proportion of the population using services directly related to the disease. Annual Prevalence with 365 Days follow up Cases meet case definition criteria to qualify in each given year with complete 365 days follow up time. Can be used as a quality measure to understand how it compares to cumulative prevalence or how it behaves over time. Page 2
3 CASE DEFINITION DIABETES MELLITUS Case Definition Type: Cumulative Prevalence Episodic Prevalence Annual Prevalence Annual Service Utilization Prevalence Annual Prevalence with 365 Days Follow up Case Definition: The case definition for Diabetes Mellitus requires one hospitalization or two physician visits in one year with diagnostic code(s) specified below; or two or more insulin prescriptions in one year; or two or more oral antihyperglycemic (not including metformin) prescriptions in one year; or one insulin and one oral antihyperglycemic (including metformin) in one year; or 2 metformin prescriptions and 1 physician visit in one year with ICD code(s) specified below. The case definition applies to persons aged 1 and older. Cases of suspected gestational diabetes in women aged are not included by excluding hospitalizations, physician claims or prescriptions within the time period 120 days preceding or 180 days after hospital records containing birth related diagnostic codes (see gestational diabetes exclusion codes below). Signed off BC Case Definition: Yes V2016 No Algorithm: 1H with ICD code(s) specified below; or 2P in 1Y with ICD code(s) specified below; or 2+Rx insulin in 1Y; or 2+Rx oral antihyperglycemic (not incl. metformin) in 1Y; or 1Rx insulin+1rx oral antihyperglycemic (incl. metformin) in 1Y; or 1Rx metformin+1rx oral antihyperglycemic (not incl. metformin) in 1Y; or 2Rx metformin+1p in 1Y with ICD code(s) specified below. Notes: None Age Restriction: Age 1 + Data Source(s): Data Source ICD Code/Procedure Code/Rx ICD Code/Procedure Code Position Hospital ICD 10 E10, E11, E13, E14 First Position Only All Positions Others N/A Hospital ICD First Position Only All Positions Others Diagnosis Type M Most Responsible Diagnosis 1 Pre Admit Comorbidity 2 Post Admit Comorbidity 3 Secondary Diagnosis 4 Morphology Code 5 Admitting Diagnosis 6 Proxy Most Responsible Diagnosis 9 External Cause of Injury Code 0 Newborn W,X,Y Service Transfer Diagnosis M Most Responsible Diagnosis 1 Pre Admit Comorbidity 2 Post Admit Comorbidity Hospital Care Level Acute Care Rehabilitation Day Surgery Acute Care Rehabilitation Day Surgery Page 3
4 N/A Physician Claims ICD First Position Only All Positions Others N/A 3 Secondary Diagnosis 4 Morphology Code 5 Admitting Diagnosis 6 Proxy Most Responsible Diagnosis 9 External Cause of Injury Code 0 Newborn W,X,Y Service Transfer Diagnosis N/A PharmaNet Drug History See drug list N/A N/A N/A N/A Diagnostic Code: ICD 9/10 Description E10 E11 E13 E14 Type 1 diabetes mellitus Type 2 diabetes mellitus Other specified diabetes mellitus Unspecified diabetes mellitus 250 Diabetes mellitus Gestational Diabetes Exclusion Codes 641 Antepartum haemorrhage, abruptio placentae, and placenta praevia 642 Hypertension complicating pregnancy, childbirth and the puerperium 643 Excessive vomiting in pregnancy 644 Early or threatened labour 645 Prolonged pregnancy 646 Other complications of pregnancy, not elsewhere classified 647 Infective and parasitic conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and puerperium 648 Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium 650 Normal delivery 651 Multiple gestation 652 Malposition and malpresentation of fetus 653 Disproportion 654 Abnormality of organs and soft tissues of pelvis 655 Known or suspected fetal abnormality affecting management of mother Page 4
5 656 Other fetal and placental problems affecting management of mother 657 Polyhydramnios 658 Other problems associated with amniotic cavity and membranes 659 Other indications for care or intervention related to labour and delivery, not elsewhere classified 660 Obstructed labor 661 Abnormality of forces of labor 662 Long labor 663 Umbilical cord complications 664 Trauma to perineum and vulva during delivery 665 Other obstetrical trauma 666 Postpartum hemorrhage 667 Retained placenta without hemorrhage 668 Complications of the administration of anesthetic or other sedation in labor and delivery 669 Other complications of labor and delivery, not elsewhere classified 670 Major puerperal infection 671 Venous complications in pregnancy and the puerperium 672 Pyrexia of unknown origin during the puerperium 673 Obstetrical pulmonary embolism 674 Other and unspecified complications of the puerperium, not elsewhere classified 675 Infections of the breast and nipple associated with childbirth 676 Other disorders of the breast associated with childbirth, and disorders of lactation 763 Fetus or newborn affected by other complications of labour and delivery V27 Outcome of delivery O10 Pre existing hypertension complicating pregnancy, childbirth and the puerperium O11 Pre eclampsia superimposed on chronic hypertension O12 Gestational [pregnancy induced] oedema and proteinuria without hypertension O13 Gestational [pregnancy induced] hypertension O14 Pre eclampsia O15 Eclampsia O16 Unspecified maternal hypertension O21 Excessive vomiting in pregnancy O22 Venous complications and haemorrhoids in pregnancy O23 Infections of genitourinary tract in pregnancy O24 Diabetes mellitus in pregnancy O25 Malnutrition in pregnancy Page 5
6 O26 O28 O29 O30 O31 O32 O33 O34 O35 O36 O37 O40 O41 O42 O43 O44 O45 O46 O47 O48 O60 O61 O62 O63 O64 O65 O66 O67 O68 O69 O70 O71 O72 O73 O74 Maternal care for other conditions predominantly related to pregnancy Abnormal findings on antenatal screening of mother Complications of anaesthesia during pregnancy Multiple gestation Complications specific to multiple gestation Maternal care for known or suspected malpresentation of fetus Maternal care for known or suspected disproportion Maternal care for known or suspected abnormality of pelvic organs Maternal care for known or suspected fetal abnormality and damage Maternal care for other known or suspected fetal problems Maternal care for decreased fetal movements Polyhydramnios Other disorders of amniotic fluid and membranes Premature rupture of membranes Placental disorders Placenta praevia Premature separation of placenta [abruptio placentae] Antepartum haemorrhage, not elsewhere classified False labour Prolonged pregnancy Preterm labour and delivery Failed induction of labour Abnormalities of forces of labour Long labour Obstructed labour due to malposition and malpresentation of fetus Obstructed labour due to maternal pelvic abnormality Other obstructed labour Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified Labour and delivery complicated by fetal stress [distress] Labour and delivery complicated by umbilical cord complications Perineal laceration during delivery Other obstetric trauma Postpartum haemorrhage Retained placenta and membranes, without haemorrhage Complications of anaesthesia during labour and delivery Page 6
7 O75 O85 O86 O87 O88 O89 O90 O91 O92 O94 O95 O98 O99 Z37 Other complications of labour and delivery, not elsewhere classified Puerperal sepsis Other puerperal infections Venous complications and haemorrhoids in the puerperium Obstetric embolism Complications of anaesthesia during the puerperium Complications of the puerperium, not elsewhere classified Infections of breast associated with childbirth Other disorders of breast and lactation associated with childbirth Sequelae of complication of pregnancy, childbirth and the puerperium Obstetric death of unspecified cause Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium Outcome of delivery Procedure Code: N/A Drug List: DIN DRUGNAME DIN DRUGNAME ACCEL PIOGLITAZONE METFORMIN ACCEL PIOGLITAZONE METFORMIN ACCEL PIOGLITAZONE METFORMIN ACCEL METFORMIN 500 MG TABLET METFORMIN ACCEL METFORMIN 500 MG TABLET METFORMIN ACCEL METFORMIN 850 MG TABLET METFORMIN ACCEL METFORMIN 850 MG TABLET METFORMIN ACC METFORMIN 500 MG TABLET METFORMIN ACC METFORMIN 850 MG TABLET METFORMIN ACH PIOGLITAZONE METFORMIN 500 MG TABLET ACH PIOGLITAZONE METFORMIN 500MG TABLET ACH PIOGLITAZONE METFORMIN 850 MG TABLET ACT GLICLAZIDE MR METFORMIN 850MG TABLET ACT GLICLAZIDE MR METFORMIN FC ACT METFORMIN METFORMIN FC Page 7
8 ACT METFORMIN METFORMIN TABLETS ACT PIOGLITAZONE METFORMIN TABLETS ACT PIOGLITAZONE METFORMIN TABLETS 500MG ACT PIOGLITAZONE METFORMIN 500 TAB 500MG ACT REPAGLINIDE METFORMIN ACT REPAGLINIDE MINT GLICLAZIDE MR ACT REPAGLINIDE MINT METFORMIN ACTOS (15MG) MINT METFORMIN ACTOS (30MG) MINT PIOGLITAZONE ACTOS (45MG) MINT PIOGLITAZONE ACTRAPID MC INJ 100UNIT/ML MINT PIOGLITAZONE AG PIOGLITAZONE MIXTARD 15/85 100U/ML VIAL AG PIOGLITAZONE MIXTARD 15/85 HUMAN INJ AMARYL MIXTARD 30/70 100U/ML VIAL AMARYL MIXTARD 30/70 100U/ML VIAL AMARYL MIXTARD 30/70 HUMAN INJ APIDRA (10ML VIAL) MIXTARD 50/ UNIT/ML VIAL APIDRA (3ML CARTRIDGE) MIXTARD 50/50 100U/ML VIAL APIDRA (3ML OPTISET PRESENTATION) MOBENOL TABLETS 500MG APIDRA (3ML SOLOSTAR DISPOSABLE PREFILLED PEN) MONOTARD MC INJ 100UNIT/ML APO CHLORPROPAMIDE TAB 100MG MYLAN GLICLAZIDE APO CHLORPROPAMIDE TAB 250MG MYLAN GLICLAZIDE MR APO GLYBURIDE TAB 2.5MG MYLAN GLICLAZIDE MR APO GLYBURIDE TAB 5MG MYLAN GLYBE APO GLICLAZIDE MYLAN GLYBE APO GLICLAZIDE MR MYLAN METFORMIN APO GLICLAZIDE MR MYLAN METFORMIN APO GLICLAZIDE MR 30 MG TABLET MYLAN PIOGLITAZONE APO GLIMEPIRIDE MYLAN PIOGLITAZONE APO GLIMEPIRIDE MYLAN PIOGLITAZONE APO GLIMEPIRIDE MYLAN REPAGLINIDE APO METFORMIN TAB 500MG MYLAN REPAGLINIDE APO METFORMIN 850 MG TABLETS MYLAN REPAGLINIDE APO METFORMIN ER MYLAN ROSIGLITAZONE Page 8
9 APO PIOGLITAZONE MYLAN ROSIGLITAZONE APO PIOGLITAZONE MYLAN ROSIGLITAZONE APO PIOGLITAZONE NESINA APO REPAGLINIDE NESINA APO REPAGLINIDE NESINA APO REPAGLINIDE NOVO BUTAMIDE 500MG APO ROSIGLITAZONE NOVO GLIMEPIRIDE APO ROSIGLITAZONE NOVO GLIMEPIRIDE APO ROSIGLITAZONE NOVO GLIMEPIRIDE APX GLICLAZIDE MR 30 MG TABLET NOVOLIN 30/70 INJ 100UNIT/ML APX GLYBURIDE 2.5 MG TABLET NOVOLIN GE 10/90 PENFILL INJ SUS APX GLYBURIDE 5 MG TABLET NOVOLIN GE 20/80 PENFILL INJ SUS APX METFORMIN 500 MG TABLET NOVOLIN GE 30/ APX METFORMIN 850 MG TABLET NOVOLIN GE 30/70 PENFILL AURO METFORMIN NOVOLIN GE 40/60 PENFILL AURO METFORMIN NOVOLIN GE 50/50 PENFILL AURO PIOGLITAZONE NOVOLIN GE LENTE INJ SC 100U/ML AURO PIOGLITAZONE NOVOLIN GE NPH AURO PIOGLITAZONE NOVOLIN GE NPH PENFILL AURO REPAGLINIDE NOVOLIN GE TORONTO AURO REPAGLINIDE NOVOLIN GE TORONTO PENFILL AURO REPAGLINIDE NOVOLIN GE ULTRALENTE INJ SUS 100U/ML AVA GLICLAZIDE NOVOLIN NPH INJ AVA GLYBURIDE NOVOLIN NPH INJ 100UNIT/ML SUSP AVA GLYBURIDE NOVOLIN ULTRALENTE SUS 100UNITS/ML AVA METFORMIN NOVOLIN LENTE INJ 100UNIT/ML AVA METFORMIN NOVOLINSET GE 30/70 INJ SUS AVANDAMET NOVOLINSET GE NPH INJ SUS 100U/ML AVANDAMET NOVOLINSET GE TORONTO INJ LIQ 100U/ML AVANDAMET NOVOLIN TORONTO INJ 100UNIT/ML AVANDAMET NOVOMIX AVANDAMET NOVOMIX 30 (FLEXPEN) AVANDARYL NOVO PROPAMIDE 250MG AVANDARYL NOVORAPID Page 9
10 AVANDARYL NOVORAPID AVANDIA NOVORAPID AVANDIA NPH BEEF & PORK HJW (D/C) AVANDIA NPH INSULIN HJW (D/C) AVANDIA 1MG TABLET NPH INSULIN 100U/ML VIAL AVA PIOGLITAZONE NPH INSULIN INJ 100UNIT/ML SUSP AVA PIOGLITAZONE NPH INSULIN PORK HAA (D/C AVA PIOGLITAZONE NPH PURIFIED PORK INSULIN INJ BASAGLAR NTP GLYBURIDE BASAGLAR NTP GLYBURIDE BCI METFORMIN NTP METFORMIN BCI METFORMIN NTP METFORMIN BYDUREON NU GLICLAZIDE BYETTA NU GLYBURIDE TAB 2.5MG BYETTA NU GLYBURIDE TAB 5MG CHLOROMIDE TAB 250MG (D/C) NU METFORMIN TAB 500MG CHLORONASE TAB 100MG (D/C) NU METFORMIN (850MG) CHLORONASE TAB 250MG (D/C) ONGLYZA CHLORPROPAMIDE 100 TAB USP ONGLYZA CHLORPROPAMIDE TAB 250MG ORAMIDE TAB 500MG (D/C) CHLORPROPAMIDE TAB 250MG ORINASE 0.5GM CHLORPROPAMIDE TAB 250MG ORINASE 1GM CHLORPROPAMIDE TAB 250MG ORINASE 1GM TABLET CO GLIMEPIRIDE ORINASE 1GM TABLET CO GLIMEPIRIDE ORINASE 500MG TABLET CO GLIMEPIRIDE ORINASE 500MG TABLET CO GLIMEPIRIDE OSENI DIABETA OSENI DIABETA OSENI DIABETA 5MG OSENI DIABETA TAB 2.5MG OSENI DIABETA TAB 5MG OSENI DIABETA TABLETS 2.5MG PENTA GLYBURIDE 2.5MG DIABINESE TAB 100MG PENTA GLYBURIDE 5MG Page 10
11 24716 DIABINESE TAB 250MG PG METFORMIN DIAMICRON PG METFORMIN DIAMICRON MR PHL METFORMIN DIAMICRON MR PHL PIOGLITAZONE DIMELOR TABLET MG PHL PIOGLITAZONE DOM GLYBURIDE PHL PIOGLITAZONE DOM GLYBURIDE PHL ROSIGLITAZONE DOM METFORMIN PHL ROSIGLITAZONE DOM METFORMIN PHL ROSIGLITAZONE DOM PIOGLITAZONE PIOGLITAZONE DOM PIOGLITAZONE PIOGLITAZONE DOM PIOGLITAZONE PIOGLITAZONE DOM ROSIGLITAZONE PIOGLITAZONE DOM ROSIGLITAZONE PIOGLITAZONE DOM ROSIGLITAZONE PIOGLITAZONE ECL METFORMIN PIOGLITAZONE HCL ECL METFORMIN PIOGLITAZONE HCL ECL PIOGLITAZONE 15 MG TABLET PIOGLITAZONE HCL ECL PIOGLITAZONE 30 MG TABLET PMS GLICLAZIDE ECL PIOGLITAZONE 45 MG TABLET PMS GLIMEPIRIDE EPERZAN PMS GLIMEPIRIDE EPERZAN PMS GLIMEPIRIDE EUGLUCON PMS GLYBURIDE EUGLUCON PMS GLYBURIDE EUGLUCON TAB 2.5MG (D/C) PMS METFORMIN EUGLUCON TAB 5MG (D/C) PMS METFORMIN TAB 500MG EUGLUCON TAB 5MG (D/C) PMS PIOGLITAZONE EUGLUCON TAB 5MG (D/C) PMS PIOGLITAZONE FORXIGA PMS PIOGLITAZONE FORXIGA PMS PIOGLITAZONE TAB 45MG GEN GLIMEPIRIDE 1MG TABLET PMS REPAGLINIDE GEN GLIMEPIRIDE 2MG TABLET PMS REPAGLINIDE GEN GLIMEPIRIDE 4MG TABLET PMS REPAGLINIDE GLIC PMS ROSIGLITAZONE Page 11
12 GLICLAZIDE PMS ROSIGLITAZONE GLICLAZIDE TAB 80MG PMS ROSIGLITAZONE GLICLAZIDE PMS ROSIGLITAZONE METFORMIN GLUCOBAY PMS ROSIGLITAZONE METFORMIN GLUCOBAY PMS ROSIGLITAZONE METFORMIN GLUCONORM 0.5MG PMS ROSIGLITAZONE METFORMIN GLUCONORM 1.0MG PMS ROSIGLITAZONE METFORMIN GLUCONORM 2.0MG PRELAY 200MG TABLET GLUCOPHAGE PRELAY 300MG TABLET GLUCOPHAGE PRELAY 400MG TABLET GLUCOPHAGE PRIVA METFORMIN GLUCOPHAGE TAB 500MG PRIVA METFORMIN GLUCOTROL 10MG XL TABLET PRO GLYBURIDE GLUCOTROL 5MG XL TABLET PRO METFORMIN GLUMETZA PRO METFORMIN GLUMETZA PRO PIOGLITAZONE GLUMETZA (SB) PRO PIOGLITAZONE GLYBURIDE PRO PIOGLITAZONE GLYBURIDE PROTAMINE ZINC HJW (D/C) GLYBURIDE 2.5MG TABLET PROTAMINE ZINC HJW (D/C) GLYBURIDE 2.5MG TABLET PROTAMINE ZINC INSULIN INJ 100UNIT/ML SUSP GLYBURIDE 5MG TABLET PROTAPHANE MC INJ 100UNIT/ML GLYBURIDE 5MG TABLET Q METFORMIN GLYBURIDE TABLETS 2.5MG Q METFORMIN GLYBURIDE TABLETS 5MG RAN GLICLAZIDE MR GLYBURIDE 2.5 TAB 2.5MG RAN METFORMIN GLYBURIDE 5 TAB 5MG RAN METFORMIN GLYCON RAN PIOGLITAZONE GLYCON 850MG RAN PIOGLITAZONE GLYSET 100MG TABLET RAN PIOGLITAZONE GLYSET 100MG TABLET RAN PIOGLITAZONE GLYSET 25MG TABLET RAN PIOGLITAZONE 15 MG TAB GLYSET 25MG TABLET RAN PIOGLITAZONE 30 MG TAB GLYSET 50MG TABLET RATIO GLIMEPIRIDE Page 12
13 GLYSET 50MG TABLET RATIO GLIMEPIRIDE GMD METFORMIN 500MG TABLET RATIO GLIMEPIRIDE GMD METFORMIN 850MG TABLET RATIO GLYBURIDE HUMALOG RATIO GLYBURIDE HUMALOG (CARTRIDGE) RATIO METFORMIN HUMALOG (KWIKPEN) RATIO METFORMIN HUMALOG 100 UNIT/ML HUMAJECT RATIO PIOGLITAZONE HUMALOG 200 UNITS/ML KWIKPEN RATIO PIOGLITAZONE HUMALOG MIX 25 (CARTRIDGE) RATIO PIOGLITAZONE HUMALOG MIX 25 (KWIKPEN) REGULAR PURIFIED PORK INSULIN INJ HUMALOG MIX 25 (PEN) REPAGLINIDE HUMALOG MIX 50 (CARTRIDGE) REPAGLINIDE HUMALOG MIX 50 (KWIKPEN) REPAGLINIDE HUMALOG PEN REZULIN HUMULIN 10/90 CARTRIDGE REZULIN HUMULIN 10/90 INJ REZULIN HUMULIN 20/80 CARTRIDGE RHOXAL METFORMIN HUMULIN 20/80 INJ RIVA GLYBURIDE HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ) RIVA GLYBURIDE HUMULIN 30/70 CARTRIDGE RIVA GLYBURIDE HUMULIN 40/60 CARTRIDGE RIVA GLYBURIDE HUMULIN 40/60 INJ RIVA METFORMIN HUMULIN 50/50 CARTRIDGE RIVA METFORMIN HUMULIN 50/50 INJ SANDOZ GLICLAZIDE HUMULIN L LENTE INJ 100UNIT/ML SUS MEDIUM SANDOZ GLIMEPIRIDE HUMULIN N SANDOZ GLIMEPIRIDE HUMULIN N (CARTRIDGE) SANDOZ GLIMEPIRIDE HUMULIN N (KWIKPEN) SANDOZ GLIMEPIRIDE HUMULIN N PEN SANDOZ GLYBURIDE HUMULIN R SANDOZ GLYBURIDE HUMULIN R (KWIKPEN) SANDOZ METFORMIN FC HUMULIN R CARTRIDGE SANDOZ METFORMIN FC HUMULIN U ULTRALENTE INJ 100UNIT/ML SANDOZ PIOGLITAZONE HYPURIN NPH INSULIN ISOPHANE PORK SANDOZ PIOGLITAZONE Page 13
14 HYPURIN REGULAR INSULIN PORK SANDOZ PIOGLITAZONE ILETIN II REG INSULIN 500U/ML SANDOZ REPAGLINIDE ILETIN INSULIN REGULAR 100UNIT/ML SANDOZ REPAGLINIDE ILETIN LENTE INSULIN INJ 100UNIT/ML SANDOZ REPAGLINIDE ILETIN NPH INSULIN 100UNIT/ML SANDOZ ROSIGLITAZONE 2 MG TAB ILETIN PROTAMINE ZINC INJ 100UNIT/ML SANDOZ ROSIGLITAZONE 4 MG TAB ILETIN SEMILENTE INSULIN INJ 100UNIT/ML SANDOZ ROSIGLITAZONE 8 MG TAB ILETIN ULTRALENTE INSULIN INJ 100UNIT/ML SAXENDA INITARD SEMILENTE INSULIN 100U/ML INITARD 100U/ML VIAL SEMILENTE INSULIN INJ 100UNIT/ML INSULATARD 100 UNIT/ML VIAL SEMILENTE RAPID HJW (D/C) INSULATARD 100 UNIT/ML VIAL SEPTA METFORMIN INSULATARD HUMAN 100U/ML VL SEPTA METFORMIN INSULATARD HUMAN INJ 100UNIT/ML SIG METFORMIN 500 MG TABLET INSULIN INSULATARD NORDISK INJ SIG METFORMIN 850 MG TABLET INSULIN MIXTARD 100U/ML VL STABINOL TAB 250MG INSULIN MIXTARD NORDISK INJ STARLIX 120MG INSULIN REGULAR SA ONLY STARLIX 180MG 5894 INSULIN TORONTO HJW (D/C) STARLIX 60MG INSULIN TORONTO 100U/ML VL SULPHATED INSUL PORK HAA (D/C) INSULIN TORONTO BEEF HAA (D/C) 6009 SULPHATED INSULIN HAA (D/C) INSULIN TORONTO INJ 100UNIT/ML SULPHATED INSULIN (D/C) INSULIN TORONTO INJ HAA (D/C) SULPHATED INSULIN INJ LIQ 100U/ML INSULIN VELOSULIN NORDISK INJ SYNJARDY INVOKAMET SYNJARDY INVOKAMET SYNJARDY INVOKAMET SYNJARDY INVOKAMET SYNJARDY INVOKAMET SYNJARDY INVOKAMET TEVA GLICLAZIDE INVOKANA TEVA GLYBURIDE INVOKANA TEVA GLYBURIDE IPG METFORMIN TEVA METFORMIN IPG METFORMIN TEVA METFORMIN Page 14
15 JAMP METFORMIN TEVA PIOGLITAZONE JAMP METFORMIN TEVA PIOGLITAZONE JAMP METFORMIN BLACKBERRY TEVA PIOGLITAZONE JAMP METFORMIN BLACKBERRY TEVA REPAGLINIDE 0.5 MG TABLET JAMP PIOGLITAZONE TEVA REPAGLINIDE 1 MG TABLET JAMP PIOGLITAZONE TEVA REPAGLINIDE 2 MG TABLET JAMP PIOGLITAZONE TEVA ROSIGLITAZONE 2 MG TABLET JANUMET TEVA ROSIGLITAZONE 4 MG TABLET JANUMET TEVA ROSIGLITAZONE 8 MG TABLET JANUMET TOLBUTAMIDE JANUMET XR TOLBUTAMIDE TAB 500MG JANUMET XR TOLBUTAMIDE TAB 500MG JANUMET XR TOLBUTAMIDE TAB 500MG JANUVIA TOLBUTAMIDE TAB 500MG (D/C) JANUVIA TOLBUTAMIDE TAB 500MG PINK JANUVIA TORRENT PIOGLITAZONE JARDIANCE TORRENT PIOGLITAZONE JARDIANCE TORRENT PIOGLITAZONE JENTADUETO TOUJEO SOLOSTAR JENTADUETO TRAJENTA JENTADUETO TRIA GLYBURIDE 2.5MG TAB KAZANO TRIA GLYBURIDE 5MG TABLET KAZANO TRIA METFORMIN 500MG TABLET KAZANO TRULICITY KOMBOGLYZE TRULICITY KOMBOGLYZE ULTRALENTE INSULIN 100U/ML KOMBOGLYZE ULTRALENTE INSULIN INJ 100UNIT/ML LANTUS ULTRALENTE ZINC HJW (D/C) LANTUS VAN METFORMIN LANTUS VAN METFORMIN LANTUS VAN PIOGLITAZONE LENTE INSULIN HAA (D/C) VAN PIOGLITAZONE LENTE INSULIN 100U/ML VIAL VAN PIOGLITAZONE LENTE INSULIN INJ 100UNIT/ML VELOSULIN 100U/ML VIAL Page 15
16 LENTE INSULIN ZINC HJW (D/C) VELOSULIN HUMAN 100U/ML VL LENTE PURIFIED PORK INSULIN INJ VELOSULIN HUMAN INJ 100UNIT/ML LEVEMIR FLEXTOUCH VELOSULIN HUMAN INJ LIQ 100U/ML LEVEMIR PENFILL VELOSULIN NORDISK NEUTRAL PORK INJ 100UNIT/ML MAR METFORMIN VELOSULIN PORK INJ 100UNIT/ML MAR METFORMIN VICTOZA MED GLYBE TAB 2.5MG VICTOZA 6 MG/ML(18 MG/3ML) PEN MED GLYBE TAB 5MG XIGDUO MED METFORMIN 850MG TABLET XIGDUO MED METFORMIN TABLETS 500MG ZYM PIOGLITAZONE METFORMIN ZYM PIOGLITAZONE METFORMIN ZYM PIOGLITAZONE METFORMIN Page 16
TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS
More informationTABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary
More informationMinistry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015
Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:
More informationTable 1. Antihyperglycemic agents for use in type 2 diabetes
Table 1. Antihyperglycemic agents for use in type 2 diabetes DRUG IN ALPHA-GLUCOSIDASE INHIBITOR: inhibits pancreatic alpha-amyle and intestinal alpha-glucoside Acarbose (Glucobay) 0.6% Negligible Not
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationObjectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Thiazolidinediones Clinical Edit Information Included in this Document Thiazolidinediones Drugs requiring prior authorization: the
More informationReport Writing Specifications
Report Writing Specifications Adverse Drug Events Primary Measures Anticoagulants, Opioids and Hypoglycemic Agents Washington State Hospital Association 2017 Contents Acknowledgements... 2 Terms Used in
More informationVictoza (Liraglutide) Solution for Injection
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationMinistry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015
Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:
More informationDIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0
Metformin DIABETES (1 of 5) Glucophage Glucophage XR ER $7 (500mg) $7 (500mg) $5 $5 500mg, 750mg only 500mg, 750mg only Sulfonylurea/Combinations Amaryl Glucotrol glimepiride glipizide $5 $5 Glucotrol
More informationVery Practical Tips for Managing Type 2 Diabetes
Very Practical Tips for Managing Type 2 Diabetes Jean-François Yale, MD, FRCPC McGill University Health Centre, Montreal, Canada Jean-francois.yale@mcgill.ca www.dryale.ca OBJECTIVES DISCLOSURES The participant
More informationGlucagon-Like Peptide (GLP-1) Receptor Agonists Clinical Edit Criteria
Glucagon-Like Peptide (GLP-1) Receptor Agonists Clinical Edit Criteria Drug/Drug Class: Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Superior HealthPlan follows the guidance of the Texas Vendor Drug
More informationFee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes
Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** December 19, 2016 Please be advised that the Department for Medicaid Services (DMS) is making changes to the Kentucky Medicaid
More informationTexas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationRPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics
Nov/Dec 2015 Issue 11 RPCC Pharmacy Forum Special Interest Articles: Diabetes Medication Chart Insulin Chart Afreeza Did you know? Exanatide, marketed as Byetta, is the synthetic form of exendin-4, which
More informationSearch strategies key terms
Online Resource - Search strategies key terms - Table S1a,b: characteristics RCTs comparing GLP-1 with insulin - Table S2a,b: characteristics observational studies comparing DPP-4i with sulfonylurea -
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Step Therapy Criteria Last Updated: March 20, 2018 Effective Date: April 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-MEDICAID
More informationClinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018
Clinical Pharmacotherapeutic Applications of the American Diabetes Association Standards of Care 2018 RACHEL NAIDA, PHARMD, CDE CLINICAL ASSOCIATE PROFESSOR UNIVERSITY OF NEW ENGLAND COLLEGE OF PHARMACY
More information1/15/2018. Disclosures. Current Diabetes Medications. Objectives NON-INSULIN AGENTS. Diabetes Med Classes. Mealtime
Disclosures Current Diabetes Medications None Claire Baker, M.D. Diabetes & Endocrine Associates January 24, 2018 Objectives Identify categories of diabetes medications Understand the pharmacology of diabetes
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationFeidhmeannacht na Seirbhíse Sláinte
Feidhmeannacht na Seirbhíse Sláinte Health Service Executive Feidhmeannacht na Seirbhíse Sláinte Seirbhís Aisíocaíochta Cúraim Phríomhúil Bealach amach 5 an M50 An Bóthar Thuaidh Fionnghlas Baile Átha
More informationDiabetes Medications: Oral Anti-Hyperglycemic Medications
Diabetes Medications: Oral Anti-Hyperglycemic Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6.
More informationPharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17
Pharmacology Updates Quang T Nguyen, FACP, FACE, FTOS 11/18/17 14 Classes of Drugs Available for the Treatment of Type 2 DM in the USA ### Class A1c Reduction Hypoglycemia Weight Change Dosing (times/day)
More informationOral and Injectable Non-insulin Antihyperglycemic Agents
Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.
More information3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
More informationDiabetes Treatment Guidelines
Diabetes Treatment Guidelines For more comprehensive information about current approaches to the diagnosis and treatment of diabetes, visit the American Diabetes Association Standards of Medical Care 2018
More informationYES = formulary NO = non-formulary NO BENEFIT = excluded
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
More informationDiabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018
Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018 Learning Objectives Identify medication classes available for treatment of individuals with diabetes. Demonstrate understanding
More informationImages have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix
Diabetes Medications Diabetes Medications Type 1 Insulin is needed Type 2 Oral Diabetes Medications Or Oral Diabetes Medications plus Insulin Or Insulin Alone Diabetes Medications Secretagogues Glipizide
More informationPhysician Drug Reference Chart for Diabetes Antidiabetic Medications
Drug Class Compound Brand Name Mechanism of Action Advantages Disadvantages Alpha-glucosidase inhibitors Medium Cost by Bayer Healthcare, Pfizer, Takeda Research Acarbose Miglitol Voglibose Precose Glyset
More informationDiabetes Mellitus II CPG
1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationHow to Fight Diabetes and Win. Diabetes. Medications
How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to
More informationOral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action
Glyburide (Micronase, Diabeta, Glynase) Glipizide (Glucotrol) Glipizide XL (Glucotrol XL) Glimepiride (Amaryl) Prandin (Repaglinide) Starlix (Nateglinide) 1.25, 2.5, 5mg tabs, Dosing: 2.5-20 mg 12- (Glynase:
More informationGHC-SCW Mandated Coverage Alphabetical Index Last Updated 8/1/2018
Search Tip: This is a large document, but you can search quickly and easily by clicking on the binocular icon on your toolbar. It will then display a search box for you to type in the name of the drug
More informationManaging Complex Diabetes Cases: Medication Update. Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM
Managing Complex Diabetes Cases: Medication Update Celia Levesque MSN, RN, CNS-BC, CDE, BC-ADM clevesqu@mdanderson.org Objectives Describe how each diabetes medication class is used to treat diabetes Differentiate
More informationCost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes
Diabetes Ther (2012) 3:7 DOI 10.1007/s13300-012-0007-6 ORIGINAL RESEARCH Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes Jason Yeaw Won Chan Lee Michael
More informationTHERAPEUTIC AREA NAME STRENGTH DOSAGE FORM
Value Based Tier Drugs are selected for the management of Asthma, Diabetes, Hypertension and Hyperlipidemia. These drugs are covered at no charge or at a reduced cost share. Medications are under continual
More informationSupplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
More informationDIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents
overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the
More informationCADTH THERAPEUTIC REVIEW New Drugs for Type 2 Diabetes: Second-Line Therapy Science Report
CADTH THERAPEUTIC REVIEW New Drugs for Type 2 Diabetes: Second-Line Therapy Science Report Product Line: Therapeutic Review Volume: Volume 4 Issue: No. 1b Publication Date: September 2017 Report Length:
More information2018 Step Therapy Criteria (List of Step Therapy Criteria)
Criteria Last Updated: October 05, 2017 Effective Date: January 1, 2018 2018 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP DUALCHOICE CAL MEDICONNECT PLAN (MEDICARE-
More informationNon-Insulin Diabetes Medications Summary
Non-Insulin Diabetes Medications Summary Medications marked with an asterisk (*) can cause hypoglycemia INSULIN SECRETAGOGUES Sulfonylureas* GLYBURIDE* (Diabeta) (Micronase) production. Side effects: Potential
More informationInformation for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets
Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable
More informationByetta (Exenatide Injection)
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
More informationDrug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4
Drug Therapy in Diabetes HEATHER TINGLE UK COLLEGE OF PHARMACY, PY4 OVERVIEW Characteristic Type 1 DM (10%) Type 2 DM (90%) Formerly known as Juvenile; Insulin-dependent Adult onset; Non-insulin dependent
More informationFormulary Medical Necessity Program
BENEFIT APPLICATION Formulary Medical Necessity Program DRUG POLICY Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations
More informationAntidiabetic Agents CHAPTER BIGUANIDES
ajt/shutterstock, Inc. CHAPTER 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS BIGUANIDES For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice for initial
More informationStep Therapy Requirements. Effective: 11/01/2018
Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK
More informationOral and Injectable Medication Options for Diabetes Treatment
Oral and Injectable Medication Options for Diabetes Treatment Presented by: Dr. Daphne E. Smith, Pharm.D., CDE Clinical Assistant Professor/Clinical Pharmacist-University of Illinois at Chicago College
More informationCollaborative Practice Agreement
Collaborative Practice Agreement [community pharmacy name] [address] [phone number] [physician practice] [address] [phone number] Effective: [date] Expiration: [date] 1 Table of Contents 1.0 Introduction...4
More informationInsulin Prior Authorization with optional Quantity Limit Program Summary
Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)
More informationStep Therapy Requirements. Effective: 05/01/2018
Step Therapy Requirements Effective: 05/01/2018 ANTIDEPRESSANTS TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK VIIBRYD 10 MG
More informationDiabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System
Diabetes Update 2018: Challenging Transitions Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System 1 Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley
More informationDiabetes Update 2018: Challenging Transitions. Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System
Diabetes Update 2018: Challenging Transitions Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley Health System 1 Patricia A. Daly, MD, FACP, FACE Medical Director for Diabetes Valley
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationPharmacologic Agents for Treatment of Type 2 Diabetes
Pharmacologic Agents for Treatment of Type 2 Diabetes SCAN Drugs Medication Biguanides 1 1 er uncoated tabs 500 mg & 750 mg Sulfonylureas 1 1 500 850 mg QD - TID 500 2000 mg glimepiride 1 1 1 8 mg glipizide
More informationDPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019
DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Januvia 50 mg tablet Janumet 50 mg-500 mg tablet Onglyza 2.5 mg tablet Januvia 100 mg tablet Onglyza 5 mg tablet Januvia 25 mg tablet Tradjenta 5 mg tablet
More informationANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria
ANTIDEPRESSANTS Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationDrug Effectiveness Review Project Summary Report Long acting Insulins
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationI. General Considerations
1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueCross BlueShield of WNY requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition.
More informationDPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet
DPP4 INHIBITORS Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet Januvia 50 mg tablet Onglyza 2.5 mg tablet Onglyza 5 mg tablet Tradjenta 5 mg tablet
More informationMinistry of Health. BC Chronic Disease and Selected Procedure Case Definitions. Chronic Disease Information Working Group. Date Created: June 29, 2015
Ministry of Health BC Chronic Disease and Selected Procedure Case Definitions Author: Chronic Disease Information Working Group Date Created: June 29, 2015 Last Updated: February 01, 2018 Version: Email:
More informationDrugs used in obstetrics
Drugs used in obstetrics Drugs used in obstetrics Drugs may be used to modify uterine contractions. These include oxytocic drugs used to stimulate uterine contractions both in induction of labour and to
More informationNew Therapies for Diabetes
Type 2 diabetes is increasingly prevalent New Therapies for Diabetes Lynn Mack, M.D. Associate Professor Diabetes, Endocrinology, & Metabolism The Nebraska Medical Center lmack@unmc.edu No Conflicts of
More informationDrugs That Require Step Therapy (ST) Step Therapy Medications
Drugs That Require Step Therapy (ST) In some cases, BlueShield of Northeastern New York requires you to first try certain drugs to treat your medical condition before we will cover another drug for that
More informationSave on your drugs with HealthyRx
Save on your drugs with HealthyRx HealthyRx is a savings program offered through the UVa Hoo s Well program. It helps lower your costs on drugs for certain health conditions. Effective 4/1/17, you are
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationMedications for Diabetes
Medications for Diabetes Sweet, but not too sweet Colette Raymond, Pharm D June 15, 2011 Learning Objectives At the end of this presentation you should be able to: Understand the prevalence and types of
More informationCRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.
ADHD STIMULANTS ATOMOXETINE HCL, DEXEDRINE 10 MG TABLET, DEXEDRINE 5 MG TABLET, DEXMETHYLPHENIDATE HCL, DEXMETHYLPHENIDATE HCL ER, DEXTROAMPHETAMINE 10 MG TAB, DEXTROAMPHETAMINE 5 MG TAB, DEXTROAMPHETAMINE
More informationDeaths Hospitalizations Company. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Takeda Pharmaceuticals. Janssen Pharmaceuticals
Takeaways: Diabetes Drug Investigation From: BSardi@aol.com Sent: Mon, Dec 22, 2014 at 10:51 am To: Cc: gemcap2@reagan.com martie.whittekin@verizon.net, katjames008@gmail.com clip_image002.jpg (64.5 KB)
More informationUnderstanding Your Diabetes: A Basic Guide
Understanding Your Diabetes: A Basic Guide Table of Contents First Steps to Managing Your Diabetes at Home When Your Blood Sugar is Too High (Hyperglycemia) Blood Sugar Targets and Blood Sugar Log How
More informationThe information in this guide comes from a government-funded review of research about pills for type 2 diabetes.
effectivehealthcare.ahrq.gov Pills for Type 2 Diabetes: A Guide for Adults Consumer Summary Guide published 5 Dec 2007 1. Introduction What does this guide cover? Type 2 diabetes means the body has a problem
More information2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for
More informationNavigating the New Options for the Management of Type 2 Diabetes
Navigating the New Options for the Management of Type 2 Diabetes Clinical Associate Professor Mark Kennedy Department of General Practice, University of Melbourne Chair, Primary Care Diabetes Society of
More information2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for
More informationDiabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:
Section #1 OBJECTIVE Diabetes Update Fall 2017 Lyle Myers BE ABLE TO DIFFERENTIATE TYPE 1 FROM TYPE 2 DIABETES Clinical features: - age at onset - body weight/bmi - family history - treatment history -
More informationUpdate on Diabetic Medications UMA SUNDARAM, M.D. DIABETES & ENDOCRINE ASSOCIATES APRIL 07, 2018
Update on Diabetic Medications UMA SUNDARAM, M.D. DIABETES & ENDOCRINE ASSOCIATES APRIL 07, 2018 Disclosure NONE Objectives To identify different categories of diabetes medications Understand the pharmacology
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More information4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis
HOW TO REGULATE DIABETES MEDICATIONS By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE Diagnosis 1 NORMAL BODY The normal pancreas releases one unit of insulin every hour all day. The normal pancreas
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More information2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements
2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements AlohaCare requires you to first try one drug to treat your medical condition before we will cover another drug for
More informationStep Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationCaring for Your Diabetes:
Inova Center for Wellness and Metabolic Health Caring for Your Diabetes: Basic Information to Help You Get Started Locations: Inova Center for Wellness and Metabolic Health Fairfax 2740 Prosperity Avenue,
More informationAdjusting Your Diabetes Medicine and Diet for a Test or Procedure
health information Adjusting Your Diabetes Medicine and Diet for a Test or Procedure The guidelines below will help you adjust your diabetes medicine and diet as you get ready for your procedure or lab
More informationContents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6
CHRISTUS Health Plan Generations (HMO) 2017 Step Therapy Criteria H1189_PC57 Accepted 11/17/2016 1 Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE
More informationDiabetes Management: A diagnostic perspective
Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite
More informationORAL AND INJECTABLE (NON-INSULIN) PHARMACOLOGICAL AGENTS FOR TYPE 2 DIABETES
ORAL AND INJECTABLE (NON-INSULIN) PHARMACOLOGICAL AGENTS FOR TYPE 2 DIABETES Joseph L. Evans, Ph.D., President, P & N Development Ventures, Saint Louis, MO USA Email: jevansphd@earthlink.net Börk Balkan,
More information2018 Diabetes Summit Managing Diabetes: An Art and a Science
2018 Diabetes Summit Managing Diabetes: An Art and a Science Natasha Petry, PharmD, BCACP NDSU College of Health Professions, School of Pharmacy, Department of Pharmacy Practice Patient-Centered Medical
More informationDiabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)
Diabetes Basics What is Diabetes? Diabetes is a disease in which the pancreas is unable to make insulin or the body is unable to use insulin or both. This leads to high blood sugar levels in the blood.
More informationWhat You Should Know About Diabetes. Laura Bingell RN Transition Center Nurse for MFP (607)
What You Should Know About Diabetes Laura Bingell RN Transition Center Nurse for MFP (607)962-8225 lbingell@ilny.org Diabetes Mellitus (DM) a group of diseases marked by high blood glucose levels. 9.3%
More information